SafeBreach software empowered a Fortune 500 biotechnology company to establish continuous security control validation across IT and OT environments, addressing remote and hybrid workforce challenges in healthcare/biotech. Moving beyond limited penetration testing and red teaming, SafeBreach Validate provided comprehensive, ongoing insights during the COVID-19 pandemic and beyond. It continuously identified and remediated gaps, ensuring robust protection for global teams with automated breach simulations. This proactive approach enhanced visibility, fortified defenses against evolving threats, and delivered resilient security posture for sustained operations.

Join for free to read